AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Tetrachlorodecaoxide
4 registrations across 3 African markets— 4 active
Markets with Tetrachlorodecaoxide
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| OXOFERIN SOLUTION (Each 100ml contains tetrachlorodecaoxide 136.9 by 106 pmd) | 🇬🇭Ghana | — | active | May 2031 |
| OXOFERIN SOLUTION (Each 100ml contains tetrachlorodecaoxide 136.9 by 106 pmd) | 🇬🇭Ghana | — | active | May 2031 |
| Oxoferin Solution Transdermal Solution | 🇰🇪Kenya | BROOKES PHARMA PRIVATE LIMITED | active | Sept 2027 |
| Oxoferin Solution | 🇹🇿Tanzania | BROOKES PHARMA PVT LIMITED | active | — |
Tetrachlorodecaoxide in Africa — Regulatory Overview
Tetrachlorodecaoxide is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Kenya, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 4 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.